The Growing Crisis of ADHD Medication Shortages

The nationwide shortage of Adderall, a commonly prescribed medication for attention deficit hyperactivity disorder (ADHD), may worsen as children head back to school. The lack of transparency in the pharmaceutical industry makes it difficult to predict when the shortages will end. ADHD medications, including Adderall alternatives, are Schedule 2 controlled substances, further complicating the production and distribution process. The ongoing shortages have left many Americans struggling to find and fill their prescriptions, impacting their ability to stay focused and complete daily tasks. The surge in demand for ADHD medications, coupled with manufacturing delays and limited production capacities, has contributed to the supply strain. Resolving the shortages requires increasing manufacturing capacity, which is challenging due to the complex nature of the pharmaceutical industry.